TRIPLEX HBV/HCV/HIV RT-PCR - India CDSCO Medical Device Registration
TRIPLEX HBV/HCV/HIV RT-PCR is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2023/000086_e36978cb511a9e7a73dc638bdaa706e6_3e8fa4d4151da884c82fc2b052d9c703. The license holder is Promea Therapeutics Private Limited, and it is classified as Device Class Class D. The approving authority is CDSCO, Zonal office, Hyderabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.
License Holder
Promea Therapeutics Private LimitedDevice Class
Approving Authority
CDSCO, Zonal office, Hyderabad
Product Information
The Triplex HBV/HCV/HIV RT-PCR kit is intended for the qualitative detection of nucleic acid from HBV, HCV and HIV in plasma samples collected from individuals for screening purpose.
Inactivation Transport Medium
Nucleic Acid Extraction Kit
Brand: ProPCR
COVID 19 RT-qPCR
Brand: ProPCR
Blood Glucose Meter Smart - GDH
Brand: P. falciparum, histidine-rich protein II
Dengue NS1 Rapid
HBsAg Rapid Kit
Brand: IgG and IgM
Blood Glucose Meter- GDH
Brand: P. falciparum, histidine-rich protein II
Blood Glucose Meter- GOD
Brand: P. falciparum, histidine-rich protein II
Blood Glucose Meter Smart - GOD
Brand: P. falciparum, histidine-rich protein II